Phase I study results of APG-115, a MDM2-p53 antagonist in Chinese patients with advanced liposarcoma and other solid tumors.

被引：0
|
作者：
Zhang, Xing
Wen, Xizhi
Chen, Guojuan
Zeng, Shan
Men, Lichuang
Wang, Hengbang
He, Shulan
Ma, Yuxiang
Pan, QiuZhong
Zhang, Yang
Peng, Ruiqing
Weng, Desheng
Liu, Wenqin
Zhang, Li
Liang, Zhiyan
Yang, Dajun
Zhai, Yifan
机构：
[1] Sun Yat Sen Univ, Melanoma & Sarcoma Med Oncol Unit, Canc Ctr, Guangzhou, Peoples R China
[2] Ascentage Pharma Suzhou Co Ltd, Suzhou, Peoples R China
[3] Sun Yat Sen Univ, Dept Med Oncol, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China
[4] Ascentage Pharma Grp Inc, Rockville, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11542
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Results of phase I clinical trials of Coramsine in patients with advanced solid tumors.
    Millward, M.
    Powell, A.
    Daly, P.
    Tyson, S.
    Ferguson, R.
    Carter, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 96S - 96S
  • [32] A phase I QTc study of tivozanib in patients with advanced solid tumors.
    Chadha, Manpreet Kaur
    Infante, Jeffrey R.
    Cotreau, Monette M.
    Jacobson, Lindsey
    Strahs, Andrew Louis
    Slichenmyer, William
    Vargo, Dennis
    Moore, Kathleen N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [33] Phase I study of sapacitabine and seliciclib in patients with advanced solid tumors.
    Tolaney, Sara M.
    Hilton, John Frederick
    Cleary, James M.
    Gandhi, Leena
    Kwak, Eunice Lee
    Clark, Jeffrey W.
    Wolanski, Andrew
    Bell, Tracy Demeo
    Rodig, Scott J.
    Chiao, Judy H.
    Blake, David
    Shapiro, Geoffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [34] A phase I study of aflibercept, pemetrexed (P), and cisplatin (C) in patients with advanced solid tumors.
    Townsley, C. A.
    Siu, L. L.
    Pedro-Salcedo, M. San
    Liu, L.
    Wakelee, H. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] A phase Ia/Ib, dose-escalation/expansion study of the MDM2-p53 antagonist BI 907828 in patients (pts) with advanced/metastatic sarcoma
    Gounder, M.
    Patel, M. R.
    Yamamoto, N.
    Bauer, T. M.
    Laurie, S.
    Perez-Pitarch, A.
    Geng, J.
    Cheng, J.
    Lahmar, M.
    Lorusso, P.
    ANNALS OF ONCOLOGY, 2021, 32 : S1124 - S1125
  • [36] Phase I study of ispinesib in combination with carboplatin in patients with advanced solid tumors.
    Jones, S. F.
    Plummer, E. R.
    Burris, H. A.
    Razak, A. R.
    Meluch, A. A.
    Bowen, C. J.
    Williams, D. H.
    Hodge, J. P.
    Dar, M. M.
    Calvert, A. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 85S - 85S
  • [37] Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumors.
    Hollebecque, Antoine
    Bahleda, Rastislav
    Thery, Jean Christophe
    Faivre, Laura
    Le Deley, Marie-Cecile
    Paci, Angelo
    Varga, Andrea
    Gazzah, Anas
    Massard, Christophe
    Poinsignon, Vianney
    Malekzadeh, Katty
    Ribrag, Vincent
    Angevin, Eric
    Postel-Vinay, Sophie
    Gomez-Roca, Carlos Alberto
    Gharib, Myriam
    Dufour, Fabienne
    Soria, Jean-Charles
    Spano, Jean-Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [38] Phase I study of MEDI0639 in patients with advanced solid tumors.
    Falchook, Gerald Steven
    Dowlati, Afshin
    Naing, Aung
    Gribbin, Matthew Joseph
    Jenkins, David William
    Chang, Linda L.
    Lai, Dominic W.
    Smith, David C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [39] A phase I study of lenalidomide and weekly docetaxel in patients with advanced solid tumors.
    Papadopoulos, K
    Mendelson, D
    Preston, GG
    Lopez, AM
    Ricart, AD
    Schwartz, G
    Needle, MN
    Gordon, MS
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9116S - 9116S
  • [40] Phase I study of sequential sapacitabine and seliciclib in patients with advanced solid tumors.
    Shapiro, Geoffrey
    Kwak, Eunice Lee
    Cleary, James M.
    Tolaney, Sara
    Gandhi, Leena
    Clark, Jeffrey W.
    Wolanski, Andrew
    Frame, Sheelagh
    Rodig, Scott J.
    Chiao, Judy H.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345